Finance

Lists
003017:SHE
Zhejiang Dayang Biotech Group Co Ltd
22,72 CN¥
-1,09%
(-0,25) 1D
16 հոկ, 15:04:45 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 003017...
Open
23,45 CN¥
High
23,77 CN¥
Low
22,50 CN¥
Mkt. cap
2,29 մլրդ
Avg. vol.
1,69 մլն
Volume
5,54 մլն
Dividend
2,42%
Quarterly dividend
0,14 CN¥
Ex-dividend date
30 սեպ, 2026 թ.
P/E ratio
21,07
52-wk high
30,82 CN¥
52-wk low
18,82 CN¥
EPS
1,08 CN¥
Shares outstanding
100,80 մլն
No. of employees
771
Open
23,45 CN¥
High
23,77 CN¥
Low
22,50 CN¥
Mkt. cap
2,29 մլրդ
Avg. vol.
1,69 մլն
Volume
5,54 մլն
Dividend
2,42%
Quarterly dividend
0,14 CN¥
Ex-dividend date
30 սեպ, 2026 թ.
P/E ratio
21,07
52-wk high
30,82 CN¥
52-wk low
18,82 CN¥
EPS
1,08 CN¥
Shares outstanding
100,80 մլն
No. of employees
771
News stories
From web sources and news partners
medwatch.com
medwatch.com
·
13 րոպե առաջ
Iambic Therapeutics raises USD 150m in Nasdaq IPO
StreetInsider
StreetInsider
·
16 րոպե առաջ
Global S&P Futures mixed in premarket
The Daily News | Texas' Oldest Newspaper
The Daily News | Texas' Oldest Newspaper
·
47 րոպե առաջ
FILE PHOTO: Traders work on the floor of the New York Stock Exchange (NYSE) in New York City
About Zhejiang Dayang Biotech Group Co Ltd
CEO-
Employees771
Founded01 հնվ, 1976 թ.
Headquarters-
SectorSpeciality chemicals
Websitedyhg.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
248,00 մլն
298,13 մլն
278,13 մլն
280,76 մլն
Cost of goods sold
190,70 մլն
238,70 մլն
212,88 մլն
219,27 մլն
Cost of revenue
190,70 մլն
238,70 մլն
212,88 մլն
219,27 մլն
Research and development expenses
10,42 մլն
16,08 մլն
9,06 մլն
14,69 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
21,90 մլն
19,40 մլն
23,53 մլն
23,25 մլն
Operating expense
23,33 մլն
43,58 մլն
30,34 մլն
37,07 մլն
Total operating expenses
214,02 մլն
282,28 մլն
243,22 մլն
256,34 մլն
Operating income
33,97 մլն
15,85 մլն
34,90 մլն
24,43 մլն
Other non operating income
-468,53 հզր
147,23 հզր
-1,34 մլն
1,02 մլն
EBT including unusual items
27,44 մլն
24,77 մլն
34,76 մլն
28,55 մլն
EBT excluding unusual items
34,44 մլն
18,83 մլն
35,18 մլն
24,71 մլն
Income tax expense
-1,92 մլն
4,37 մլն
3,86 մլն
2,53 մլն
Effective tax rate
-7,00%
17,62%
11,09%
8,87%
Other operating expenses
-8,84 մլն
7,19 մլն
-4,28 մլն
659,38 հզր
Net income
29,53 մլն
19,82 մլն
30,87 մլն
26,60 մլն
Net profit margin
11,91%
6,65%
11,10%
9,47%
Earnings per share
-
-
-
-
Interest and investment income
2,37 մլն
3,66 մլն
2,41 մլն
2,33 մլն
Interest expense
-940,75 հզր
-919,14 հզր
-785,64 հզր
-882,93 հզր
Net interest expenses
1,43 մլն
2,74 մլն
1,62 մլն
1,45 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
50,83 մլն
33,69 մլն
52,73 մլն
42,22 մլն
Gain or loss from assets sale
-
-2,05 մլն
-
21,12 հզր
AI content may include mistakes. Learn more
Google Apps